首站-论文投稿智能助手
典型文献
Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway
文献摘要:
The incidence of endometrial cancer(EC)increases annually and tends to occur in younger women.A particularly important relationship exists between EC and metabolic disorders.As one of the most important components of lipid metabolism,phospholipids play an indispensable role in metabolic balance.LPCAT1 is a key enzyme regulating phospholipid metabolism.In this study,we perform further investigations to seek mechanistic insight of LPCAT1 in EC.Our results demonstrate that silencing of LPCAT1 inhibits the growth of endometrial cancer,while over-expression of LPCAT1 results in enhanced stemness and metastasis in endometrial cancer cell lines.Meanwhile,the contents of various phospholipids including phosphatidylethanolamine(PE),phosphatidylcholine(PC),and trigly-ceride(TG)change significantly after overexpression of LPCAT1.In addition,through RNA-sequencing and western blot analysis,we observe that the TGF-β/Smad2/3 signaling pathway is of great importance in the tumor-promoting function of LPCAT1.LPCAT1 promotes the expressions of stem cell-related transcription factors and epithelial-mesenchymal transition(EMT)related proteins through the TGF-β/Smad2/3 signaling pathway.Moreover,we find that TSI-01,which can inhibit the activity of LPCAT1,is able to restrain the proliferation of EC cell lines and promote cell apoptosis.Collectively,we demonstrate that LPCAT1 enhances the stemness and metastasis of EC by activating the TGF-β/Smad2/3 signaling pathway and that TSI-01 may have potential use for the treatment of EC.
文献关键词:
作者姓名:
Tianyi Zhao;Rui Sun;Xiaohong Ma;Lina Wei;Yixin Hou;Kun Song;Jie Jiang
作者机构:
Department of Gynecology and Obstetrics,Qilu Hospital,Cheeloo College of Medicine,Shandong University,Jinan 250012,China
引用格式:
[1]Tianyi Zhao;Rui Sun;Xiaohong Ma;Lina Wei;Yixin Hou;Kun Song;Jie Jiang-.Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway)[J].生物化学与生物物理学报(英文版),2022(07):904-916
A类:
LPCAT1,trigly,ceride
B类:
Overexpression,enhances,endometrial,cancer,stemness,metastasis,by,changing,components,activating,TGF,Smad2,signaling,pathway,incidence,EC,increases,annually,tends,occur,younger,women,particularly,important,relationship,exists,between,metabolic,disorders,most,metabolism,phospholipids,play,indispensable,role,balance,key,enzyme,regulating,In,this,study,perform,further,investigations,seek,mechanistic,insight,Our,results,demonstrate,that,silencing,inhibits,growth,enhanced,cell,lines,Meanwhile,contents,various,including,phosphatidylethanolamine,PE,phosphatidylcholine,change,significantly,after,overexpression,addition,through,sequencing,western,blot,analysis,observe,great,importance,tumor,promoting,function,promotes,expressions,related,transcription,factors,epithelial,mesenchymal,transition,EMT,proteins,Moreover,find,TSI,which,activity,restrain,proliferation,apoptosis,Collectively,may,have,potential,use,treatment
AB值:
0.481438
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways
Wan Li;Hongqing Cai;Liwen Ren;Yihui Yang;Hong Yang;Jinyi Liu;Sha Li;Yizhi Zhang;Xiangjin Zheng;Wei Tan;Guanhua Du;Jinhua Wang-The State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Beijing 100050,China;Key Laboratory of Drug Target Research and Drug Screen,Institute of Materia Medica,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100050,China;Department of Neurosurgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;State Key Laboratory of Molecular Oncology,Center for Cancer Precision Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;School of Pharmacy,Xinjiang Medical University,Urumqi 830011,China;Xinjiang Institute of Materia Medica,Urumqi 830004,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。